Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Ruben Gabriels
dr.
Overview
Fingerprint
Network
Research output
(28)
Similar Profiles
(7)
Research output
12
Article
9
Meeting Abstract
3
Review article
2
Abstract
2
More
1
Patent
1
Thesis fully internal (DIV)
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Abstract
Search results
2020
Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts
Biemans, V. B. C., Savelkoul, E.,
Dijkstra, G.
, Simsek, M.,
Gabriels, R. Y.
, Pierik, M., West, R., de Boer, N. & Hoentjen, F.,
15-Jan-2020
,
p. S404-S405
.
2 p.
Research output
:
Contribution to conference
›
Abstract
›
Academic
2016
In a Dutch real-life inflammatory bowel disease score cohort with 90% prior anti-tumour necrosis factor failure, vedolizumab showed a 25% remission rate: a retrospective multicentre study
Gabriëls, R. Y.
, de Graaf, A. P. J., Meijssen, M. A. C., Gotz, J., Mensink, P., Russel, M.,
van Dullemen, H.
, ter Steege, R. W. F.,
Weersma, R.
&
Dijkstra, G.
,
2016
.
Research output
:
Contribution to conference
›
Abstract
›
Academic
Inflammatory Bowel Disease
100%
Spontaneous Remission
100%
Tumor Necrosis
100%
Vedolizumab
100%
Crohn's Disease
70%